EMEA-002342-PIP01-18-M02

Table of contents

Key facts

Invented name
Verzenios
Active substance
abemaciclib
Therapeutic area
Oncology
Decision number
P/0440/2021
PIP number
EMEA-002342-PIP01-18-M02
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of Ewing sarcoma
Route(s) of administration
Oral use
Contact for public enquiries
Eli Lilly and Company Limited

E-mail: EU_PAEDIATRIC@LILLY.COM
Tel.   +44 1344382427

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating